Brief: HOOKIPA Pharma Q2 Net Income USD -18.016 Million
10/08/2023 12:01
Aug 10 (Reuters) - HOOKIPA Pharma Q2 revenue USD 2.679 million. * Q2 operating expenses USD -24.151 million * Q2 operating income USD -21.472 million * Q2 basic EPS USD -0.22
Recent news on Hookipa Pharma
See all newsBrief: Hookipa Pharma Announces Sale Of Oncology Assets To Neotrail Therapeutics
Brief: Hookipa Pharma Announces Intention To Voluntarily Delist And Deregister Its Common Stock
Hookipa Pharma Inc Expected To Post A Loss Of $1.04 A Share: Earnings Preview
Brief: Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)